ArticleBioMed research international2024

Retracted: Distinct Molecular Subtypes of Diffuse Large B Cell Lymphoma Patients Treated with Rituximab-CHOP Are Associated with Different Clinical Outcomes and Molecular Mechanisms.

BioMed Research InternationalPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.